Pharmakia Holding ApS Financials, key figures and credit report
Gross profit -12.0 kDKK FY 2025 +0.8% vs 2024
EBIT -12.0 kDKK FY 2025 +0.8% vs 2024
Net debt - 554.1 kDKK FY 2025 -339.9% vs 2024
Quick ratio 3.8 FY 2025 +3 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -7.50 | -7.25 | -9.14 | -12.06 | -11.97 |
| EBIT | -7.50 | -7.25 | -9.14 | -12.06 | -11.97 |
| Other financial income | 0.40 | 0.10 | 1.44 | 12.97 | |
| Other financial expenses | -1.44 | -1.69 | -0.51 | -14.46 | -22.91 |
| Net income from associates (fin.) | 194.70 | - 169.62 | - 121.97 | 1 511.70 | 734.43 |
| Pre-tax profit | 186.17 | - 178.46 | - 130.18 | 1 498.15 | 699.54 |
| Income taxes | 1.77 | -3.50 | 5.02 | 5.96 | |
| Net earnings | 187.94 | - 181.97 | - 130.18 | 1 503.16 | 705.50 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Holdings in group member companies | 83.13 | 118.43 | 1 852.11 | 1 386.54 | |
| Participating interests | 195.13 | 50.40 | |||
| Investments total | 278.26 | 50.40 | 118.43 | 1 852.11 | 1 386.54 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 32.99 | 44.56 | |||
| Current deferred tax assets | 53.50 | 14.00 | 523.53 | 335.96 | |
| Short term receivables total | 86.49 | 58.56 | 523.53 | 335.96 | |
| Cash and bank deposits | 144.39 | 277.40 | 20.81 | 194.70 | 852.43 |
| Cash and cash equivalents | 144.39 | 277.40 | 20.81 | 194.70 | 852.43 |
| Balance sheet total (assets) | 509.14 | 327.79 | 197.80 | 2 570.34 | 2 574.92 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Shares repurchased | 135.00 | ||||
| Other reserves | 208.26 | 30.40 | 612.11 | 1 346.54 | |
| Retained earnings | 54.69 | 420.49 | 268.92 | - 608.37 | 160.37 |
| Profit of the financial year | 187.94 | - 181.97 | - 130.18 | 1 503.16 | 705.50 |
| Shareholders equity total | 500.89 | 318.92 | 188.74 | 1 691.90 | 2 262.41 |
| Non-current liabilities total | |||||
| Current trade creditors | 6.25 | 6.88 | 6.88 | 6.50 | 6.50 |
| Current owed to group member | 425.71 | 298.29 | |||
| Short-term deferred tax liabilities | 440.31 | ||||
| Other non-interest bearing current liabilities | 2.00 | 2.00 | 2.19 | 5.92 | 7.72 |
| Current liabilities total | 8.25 | 8.88 | 9.06 | 878.44 | 312.52 |
| Balance sheet total (liabilities) | 509.14 | 327.79 | 197.80 | 2 570.34 | 2 574.92 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated